These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 15056086

  • 1. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis.
    Lobel EZ, Korelitz BI, Xuereb MA, Panagopoulos G.
    Am J Gastroenterol; 2004 Mar; 99(3):462-5. PubMed ID: 15056086
    [Abstract] [Full Text] [Related]

  • 2. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 3. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
    Adler DJ, Korelitz BI.
    Am J Gastroenterol; 1990 Jun; 85(6):717-22. PubMed ID: 1972315
    [Abstract] [Full Text] [Related]

  • 4. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [Abstract] [Full Text] [Related]

  • 5. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
    George J, Present DH, Pou R, Bodian C, Rubin PH.
    Am J Gastroenterol; 1996 Sep; 91(9):1711-4. PubMed ID: 8792685
    [Abstract] [Full Text] [Related]

  • 6. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T.
    J Gastroenterol; 2003 Sep; 38(8):740-6. PubMed ID: 14505127
    [Abstract] [Full Text] [Related]

  • 7. The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
    Glazier KD, Palance AL, Griffel LH, Das KM.
    J Clin Gastroenterol; 2005 Jan; 39(1):21-6. PubMed ID: 15599205
    [Abstract] [Full Text] [Related]

  • 8. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S, Nakase H, Matsuura M, Masuda S, Inui K, Chiba T.
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [Abstract] [Full Text] [Related]

  • 10. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G.
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
    Kim DU, Kim YH, Kim BJ, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC.
    Hepatogastroenterology; 2009 Jun; 56(94-95):1395-402. PubMed ID: 19950798
    [Abstract] [Full Text] [Related]

  • 12. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [Abstract] [Full Text] [Related]

  • 13. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study.
    Lau A, Chande N, Ponich T, Gregor JC.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):606-13. PubMed ID: 18564323
    [Abstract] [Full Text] [Related]

  • 14. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A.
    Am J Gastroenterol; 2009 Feb 01; 104(2):437-43. PubMed ID: 19174792
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 01; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 16. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
    Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA.
    Am J Gastroenterol; 2008 May 01; 103(5):1203-9. PubMed ID: 18422816
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and usefulness of mercaptopurine in azathioprine-intolerant Japanese patients with ulcerative colitis.
    Kuriyama M, Kato J, Suzuki H, Akita M, Hiraoka S, Okada H, Yamamoto K.
    Dig Endosc; 2010 Oct 01; 22(4):289-96. PubMed ID: 21175481
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
    Tajiri H, Tomomasa T, Yoden A, Konno M, Sasaki M, Maisawa S, Sumazaki R, Shimizu T, Toyoda S, Etani Y, Nakacho M, Ushijima K, Kobayashi A, Japanese Society for Pediatric Inflammatory Bowel Disease.
    Digestion; 2008 Oct 01; 77(3-4):150-4. PubMed ID: 18577852
    [Abstract] [Full Text] [Related]

  • 19. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.
    Sakuraba A, Sato T, Morohoshi Y, Matsuoka K, Okamoto S, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T.
    Ther Apher Dial; 2012 Jun 01; 16(3):213-8. PubMed ID: 22607563
    [Abstract] [Full Text] [Related]

  • 20. Age as a clinical predictor of relapse after induction therapy in ulcerative colitis.
    Jang ES, Lee DH, Kim J, Yang HJ, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N, Jung HC, Song IS.
    Hepatogastroenterology; 2009 Jun 01; 56(94-95):1304-9. PubMed ID: 19950781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.